Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/sage/genetic-risk-assessment-for-adult-children-of-people-with-alzheimer-s-Ys0AdGgZt0
References (29)
-
D. Cella, Chanita Hughes, A. Peterman, Chih-Hung Chang, B. Peshkin, M. Schwartz, L. Wenzel, A. Lemke, A. Marcus, C. Lerman (2002)
A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 21 6
-
L. Cupples, N. Risch, L. Farrer, R. Myers (1991)
Estimation of morbid risk and age at onset with missing information.American journal of human genetics, 49 1
-
Scott Roberts, M. Lock, Janalyn Prest, Melissa Barber, P. Whitehouse, Susan Larusse, N. Relkin, Tamsen Brown, R. Green (2004)
P4-121 How does genetic testing affect anxiety about developing ad? Findings from a randomized clinical trialNeurobiology of Aging, 25
-
S. Humphries, D. Betteridge, P. Durrington, D. Galton, P. Nicholls (1996)
Apolipoprotein E genotyping in Alzheimer's disease.Lancet, 347 9017
-
(2000)
Alzheimer disease and the fronto-temporal dementias: diseases with cerebral deposition of fibrillar proteins -
L. Cupples, L. Farrer, A. Sadovnick, N. Relkin, P. Whitehouse, R. Green (2004)
Estimating risk curves for first-degree relatives of patients with Alzheimer’s disease: The REVEAL studyGenetics in Medicine, 6
-
D. Roter, M. Stewart, S. Putnam, M. Lipkin, W. Stiles, T. Inui (1997)
Communication patterns of primary care physicians.JAMA, 277 4
-
T. Marteau, Scott Roberts, Susan Larusse, R. Green (2005)
Predictive Genetic Testing for Alzheimer's Disease: Impact upon Risk PerceptionRisk Analysis, 25
-
C. Zick, Charles Mathews, J. Roberts, R. Cook-Deegan, Robert Pokorski, R. Green (2005)
Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior.Health affairs, 24 2
-
P. Panegyres, C. Connor, T. Liebeck, J. Goldblatt, I. Walpole, K. Harrop (2000)
Genetic testing for Alzheimer's diseaseMedical Journal of Australia, 172
-
K. Garver, Bettylee Garver (1994)
The Human Genome Project and eugenic concerns.American journal of human genetics, 54 1
-
Scott Roberts, Susan Larusse, H. Katzen, P. Whitehouse, Melissa Barber, S. Post, N. Relkin, K. Quaid, R. Pietrzak, A. Cupples, L. Farrer, Tamsen Brown, R. Green (2003)
Reasons for Seeking Genetic Susceptibility Testing Among First‐Degree Relatives of People With Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 17
-
R. Green, L. Cupples, R. Go, K. Benke, T. Edeki, P. Griffith, Maryanne Williams, Pac Hipps, N. Graff-Radford, D. Bachman, L. Farrer (2002)
Risk of dementia among white and African American relatives of patients with Alzheimer disease.JAMA, 287 3
-
D. Blacker, R. Tanzi (1998)
The genetics of Alzheimer disease: current status and future prospects.Archives of neurology, 55 3
-
J. Roberts, Melissa Barber, Tamsen Brown, L. Cupples, L. Farrer, Susan Larusse, S. Post, K. Quaid, L. Ravdin, N. Relkin, A. Sadovnick, P. Whitehouse, J. Woodard, R. Green (2004)
Who seeks genetic susceptibility testing for Alzheimer’s disease? Findings from a multisite, randomized clinical trialGenetics in Medicine, 6
-
Susan Larusse, J. Roberts, T. Marteau, H. Katzen, Erin Linnenbringer, Melissa Barber, P. Whitehouse, K. Quaid, Tamsen Brown, R. Green, N. Relkin (2005)
Genetic susceptibility testing versus family history–based risk assessment: Impact on perceived risk of Alzheimer diseaseGenetics in Medicine, 7
-
N. Lautenschlager, L. Cupples, V. Rao, S. Auerbach, R. Becker, J. Burke, H. Chui, R. Duara, E. Foley, S. Glatt, R. Green, Randi Jones, H. Karlinsky, W. Kukull, A. Kurz, Eric Larson, K. Martelli, A. Sadovnick, L. Volicer, S. Waring, J. Growdon, L. Farrer (1996)
Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE studyNeurology, 46
-
L. Farrer, M. Brin, L. Elsas, A. Goate, J. Kennedy, R. Mayeux, R. Myers, P. Reilly, N. Risch (1995)
Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease.JAMA, 274 20
-
Lindsay Farrer, L. Cupples, S. Blackburn, D. Kiely, S. Auerbaeh, J. Growdon, L. Connor-Lacke, H. Karlinsky, H. Karlinsky, A. Thibert, James Burke, C. Utley, Helena Chui, A. Ireland, R. Duara, R. Duara, R. Lopez-Alberola, Eric Larson, S. O’Connell, W. Kukull (1994)
Interrater agreement for diagnosis of Alzheimer's diseaseNeurology, 44
-
(2003)
How do participants rate the impact of genetic susceptibility testing for Alzheimer’s disease -
Colin Masters, K. Beyreuther (1998)
Science, medicine, and the future: Alzheimer's diseaseBMJ, 316
-
(2002)
Participant recall of their own Apolipoprotein E (APOE) genotype results and risk estimate after 6 weeks: results from the REVEAL Study -
G. Evans (1998)
The Human Genome Project: applications in the diagnosis and treatment of neurologic disease.Archives of neurology, 55 10
-
L. Farrer, L. Cupples, J. Haines, B. Hyman, W. Kukull, R. Mayeux, R. Myers, M. Pericak-Vance, N. Risch, C. Duijn (1997)
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysisJAMA, 278
-
A. Roses (1997)
Genetic testing for Alzheimer disease. Practical and ethical issues.Archives of neurology, 54 10
-
L. McConnell, B. Koenig, H. Greely, T. Raffin (1998)
Genetic testing and Alzheimer disease: Has the time come?Nature Medicine, 4
-
J. Roberts, F. Blow, J. Coyne, S. Nolen-Hoeksema, Christopher Peter-Son, K. Welsh-Bohmer, Raymond Thanks, Bingham, Scott Roberts (2000)
Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives.The Gerontologist, 40 1
-
H. Karlinsky, Sadovnick Ad, Michael Burgess, Sylvie Langlois, Michael Hayden, Berg Jm (1994)
Issues in Molecular Genetic Testing of Individuals with Suspected Early‐onset Familial Alzheimer's DiseaseAlzheimer Disease & Associated Disorders, 8
-
S. Post, P. Whitehouse, R. Binstock, T. Bird, S. Eckert, L. Farrer, L. Fleck, A. Gaines, E. Juengst, H. Karlinsky, S. Miles, T. Murray, K. Quaid, N. Relkin, A. Roses, P. George-hyslop, G. Sachs, B. Steinbock, E. Truschke, A. Zinn (1997)
The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.JAMA, 277 10
- Publisher
- SAGE
- Copyright
- Copyright © 2019 by SAGE Publications
- ISSN
- 0891-9887
- eISSN
- 1552-5708
- DOI
- 10.1177/0891988705281883
- Publisher site
- See Article on Publisher Site
Abstract
As genetic risk factors continue to be identified for common, complex adult-onset diseases, it will become increasingly important to understand if, how, and when to translate these discoveries into clinical practice. This article provides an overview of and results to date from the REVEAL study, a multisite randomized clinical trial (n = 162) examining the impact of a genetic risk assessment program, including apolipoprotein E genotype disclosure, for adult children of people with Alzheimer’s disease. The study’s rationale and procedures are described, including the generation of numerical lifetime risk curves for use in the education and counseling protocol. Findings are summarized across numerous study questions, including (1) who seeks genetic risk assessment and why, (2) how apolipoprotein E results affect risk perceptions, (3) the psychological impact of genetic risk assessment, and (4) how risk information affects participants’ subsequent health and insurance behaviors.
Journal
Journal of Geriatric Psychiatry and Neurology – SAGE
Published: Jun 29, 2016
Keywords: Alzheimer’s disease,genetic testing,apolipoprotein E,risk assessment